Sosei
Genentech extends small-molecule R&D with three platform deals
Phil Taylor
Genentech, licensing, research and development, Roche, Sosei
0 Comment
X
Genentech extends small-molecule R&D with three platform deals
https://pharmaphorum.com/news/genentech-extends-small-molecule-rd-with-three-platform-deals/
X
Pfizer selects first GPCR candidate from Sosei Heptares tie-up
https://pharmaphorum.com/news/pfizer-selects-first-gpcr-candidate-from-sosei-heptares-tie-up/
X
Shinichi Tamura re-takes CEO role at Sosei
https://pharmaphorum.com/news/shinichi-tamura-re-takes-ceo-role-sosei/
X
Sosei shares tank after safety issue with Alzheimer’s drug
https://pharmaphorum.com/news/sosei-shares-tank-after-safety-issue-with-alzheimers-drug/
Sosei see Teva pipeline cull as an opportunity
Linda Banks
CGRP, Heptares, migraine, Sosei, Teva
0 Comment
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
X
Sosei see Teva pipeline cull as an opportunity
https://pharmaphorum.com/news/sosei-loses-teva-culls-migraine-pipeline/